Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
66554501000001117 | Bevacizumab 1.25mg/0.05ml solution for injection vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
66554601000001118 | Bevacizumab 1.25mg/0.05ml solution for injection vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Avastin 1.25mg/0.05ml solution for injection vials (Special Order) | Is a | True | Bevacizumab 1.25mg/0.05ml solution for injection vials | Inferred relationship | Existential restriction modifier | |
Bevacizumab 1.25mg/0.05ml solution for injection vials 1 ml | Has VMP | True | Bevacizumab 1.25mg/0.05ml solution for injection vials | Inferred relationship | Existential restriction modifier | |
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) | Is a | True | Bevacizumab 1.25mg/0.05ml solution for injection vials | Inferred relationship | Existential restriction modifier | |
Bevacizumab 1.25mg/0.05ml solution for injection vials 1 vial | Has VMP | True | Bevacizumab 1.25mg/0.05ml solution for injection vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets